News
February 5, 2019

Regenstrief Scientist Says African Americans Have Higher Rate of Alzheimer’s Disease, Quoted in USA Today

Daniel Bateman, M.D., says a number of studies show a higher rate of Alzheimer’s disease in African Americans. He told USA Today there are some hypotheses to explain this.

“There are higher rates of diabetes, hypertension, high cholesterol, heart disease and diabetes in African Americans compared to whites. All of those are risk factors for Alzheimer’s and dementia,” said Dr. Bateman. He points to a 2018 study, which also looked at a number of factors of people who have had a stroke, that found that African Americans had an increased rate for all five types of dementia.

Joanne Pike, vice president of programs for the Alzheimer’s Association in Chicago, says that African Americans are twice as likely to have Alzheimer’s, less likely to receive a diagnosis and more likely to be diagnosed in later stages of the disease. Researchers are looking at many avenues to understand the reasons why.

Regenstrief Institute does a large amount of work in the area of Alzheimer’s and dementia. From testing new care models to decision support and the effects of medication on the brain.  Dr. Bateman’s work is focused on Alzheimer’s disease, specifically innovative approaches to measure and treat behavioral and psychological symptoms of dementia by leveraging technologies. He serves as a co-investigator on the Indiana Alzheimer Disease Center (IADC) Outreach and Recruitment (OR) Core and contributes to the IADC Clinical Core.

Read the USA Today article featuring Dr. Bateman here.

  • Daniel Bateman

Related News

photo of nursing home worker working a puzzle with an elderly woman

Assessing pain, anxiety and other symptoms of nursing home residents unable to speak for themselves

Revamped tool reliably addresses physical and emotional distress, well-being and end-of-life symptoms INDIANAPOLIS – As many as half of

LOINC® spring stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® spring stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® from Regenstrief Institute will host a biannual stakeholder meeting on March 25, 2025. During the meeting, held via

AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow

Non-invasive, inexpensive approach provides a practical option for proactive screening INDIANAPOLIS – AFib (short for atrial fibrillation), a common